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Neural progenitor cellsDevelopmental neurotoxicity (DNT) refers to the toxic effects induced by various chemicals on brain during the
early childhood period. As human brains are vulnerable during this period, various chemicals would have signif-
icant effects on brains during early childhood. Some toxicants have been conﬁrmed to induce developmental
toxic effects on CNS; however,most of agents cannot be identiﬁedwith certainty. This is because available animal
models do not cover the whole spectrum of CNS developmental periods. A novel alternative method that can
overcome most of the limitations of the conventional techniques is the use of 3D neurosphere system. This in-
vitro system can recapitulate many of the changes during the period of brain development making it an ideal
model for predicting developmental neurotoxic effects. In the present study we veriﬁed the possible DNT of
Malathion, which is one of organophosphate pesticides with suggested possible neurotoxic effects on nursing
children. Three doses of Malathion (0.25 μM, 1 μM and 10 μM) were used in cultured neurospheres for a period
of 14 days. Malathionwas found to affect proliferation, differentiation and viability of neurospheres, these effects
were positively correlated to doses and time progress. This study conﬁrms the DNT effects of Malathion on 3D
neurosphere model. Further epidemiological studies will be needed to link these results to human exposure
and effects data.
© 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pesticides are important chemicals used widely in agriculture, and
their use has improved the yield of plants for food leading to reduced
food costs. However, the problem with the wide use of pesticides is
that they generally persist in the environment. This in turn causes se-
vere environmental pollution and potential acute and chronic cases of
human poisoning (Dallegrave et al., 2007; Yen et al., 2000). Organo-
phosphorus pesticides (OPs) are currently the most commonly utilized
pesticides worldwide. They combine almost 40 different chemical
members registered by the US-EPA (EPA, 2002). About 70% of all insec-
ticides used in USA are OPs, constituting about 73 million pounds
in 2001 (Kiely, 2004). Besides, OP toxicity is considered a massive con-
cern in developed as well as low-income countries (Rohlman et al.,
2011). The cholinesterase enzymes inhibiting effects of OPs represent
the main mechanism underlying their acute toxicity. However, other
possible toxic effects have been linked to chronic exposure to OPsed).
en access article under the CC BY-NC(e.g. delayed neurotoxicity, developmental neurotoxicity and other
organs' toxicity) (Abou-Donia, 2003). The OP Malathion (O, O-
dimethyl dithiophosphate of diethyl mercaptosuccinate) is one of the
OPswith variable toxic effects (RED, 2006).Malathion has several appli-
cations worldwide to control major arthropods in public health pro-
grams e.g. for animal ectoparasites, human head and body lice, also it
is used as a household insecticide and to protect grain in storage
(Maroni et al., 2000). Malathion bioactive metabolite, malaoxon, is
known to induce excitotoxicity (Hazarika et al., 2003). It is noteworthy
that, many researches proved neurotoxic effects of malathion both in
humans and experimental animals (Vidair, 2004; Abdel-Rahman et al.,
2004). One of the possible risks of Malathion is its effect during early
childhood. Recent studies showed that exposure of postnatal pups
to Malathion via lactation inhibits the activity of brain, plasma and
erythrocyte cholinesterase in the pups (Selmi et al., 2012). Additionally,
similarities exist between Malathion and lead (pb) (which is a known
neurotoxicant that affects early brain development) regarding their
increasing BBB permeability by similar mechanisms (Balbuena et al.,
2011). Likewise, recent ﬁndings suggest that Malathion exposure
during lactation induced biochemical cerebral alterations and oxidative-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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coordination, vestibular function and muscular strength/coordination)
in rat pups (Acker et al., 2011) and behavioral and morphological defor-
mities in freshwaterﬁsh (Patil andDavid, 2010) have been observed as a
result ofMalathion exposure in postnatal animals and by analogy human
neonates. Thesemay be correlated to the lower levels of the enzymes in-
volved in organophosphate deactivation in this critical developmental
age. As described previously, OP (including Malathion) exert their toxic
effects by inhibiting acetylcholinesterase enzyme (AChE) through phos-
phorylation of the serine residue at its active site. The main function of
AChE is to hydrolyze the neurotransmitter acetylcholine (ACh) to choline
and acetate during neurotransmission at cholinergic synapses (Wang
et al., 2009). The developing brain is extremely vulnerable to neuroactive
chemicals that elicit or block neurotransmitter responses during periods
of rapid brain growth. Hence, AChE, through affecting ACh, will affect
brain development (Yanai, 1984). Since the tragedy of Minamata-
Japan, the term of developmental neurotoxicity (DNT) has been coined
to verify chemical-induced toxic effects of substances on growing brains
of children (Lein et al., 2007). This has been recognized as a serious threat
to human health (Needleman et al., 2002). Current DNT testing guide-
lines (Organization for Economic Cooperation and Development, 2007)
propose investigations in rodents, mainly rats. Such testing strategy,
however, implies the use of 140 dams and 1000 pups,which is extremely
time- and cost-intensive (Lein et al., 2005). Relying mainly on the
existing in-vivo testing strategies for DNT of the many toxic substances
would demand huge and unacceptable costs in terms of animals and
person-years (Lein et al., 2007). Therefore, according to the “3R princi-
ple” (reduction, replacement, and reﬁnement) of Russel and Burch
(1959), alternative testing strategies are needed to create affordable,
sensitive, and mechanism-based methods suitable for high- or
medium-throughput screening (Collins et al., 2008).
The search for better alternatives for animalmodels advocated some
potential in vitromodels for toxicity testing thatmimicmost of the basal
processes of brain development in the culture dish. The most promising
models for DNT testing are based on three-dimensional animal or human
cell culture systems: the embryonic stem cell test (EST) (Genschow,
2002), the whole embryo culture (WEC) and neural progenitor cells
(NPCs), grown as neurospheres (Zhang et al., 2001). The three-
dimensional neurosphere system mirrors the basic processes of brain
development, namely proliferation, migration, differentiation and apo-
ptosis. So far, however, research with neurospheres has largely focused
on their application for neuroregeneration in disease states of the cen-
tral nervous system (Iwanami et al., 2005). Nevertheless, a few studies
have also utilized neurospheres for toxicity studies in vitro by analyzing
a variety of endpoints such as viability, proliferation, migration, differ-
entiation, neurite outgrowth and apoptosis (Meacham et al., 2005).
These provide support for their use in hazard identiﬁcation screens
for chemicals that may cause developmental neurotoxicity. Since ef-
fect of Malathion on growing brain is one of the areas of concern in
neurotoxicology, in the present study, we investigated the impact of
Malathion on neurosphere endpoints (e.g. proliferation, differentiation
and neurite outgrowth) trying to extrapolate the resulting data to devel-
opmental toxic effects leading to gross morphological brain changes.
In addition, the role of two suggested mechanisms; oxidative stress
and acetyl cholinesterase (AchE) inhibition, for this neurotoxic effect of
Malathionon culturedneurosphereswas investigated (Selmi et al., 2012).
2. Materials and methods
All chemicals were of molecular biology grade and were obtained
from Sigma-Aldrich (USA) unless otherwise stated.
2.1. Cell culture
Rat neural progenitor cells were isolated from rat embryos (E14)
extracted from placental tissue. The cortices were aseptically dissectedout from the brains of the fetuses and the tissues were triturated by re-
peated passage through a ﬁre-polished constricted Pasteur pipette. The
dispersed tissues were allowed to settle for 3min. The supernatant was,
then, transferred to a fresh tube and centrifuged at 1000 g for 5min. The
pellet was placed in Hank's balanced salt solution cultured as free-
ﬂoating neurospheres in proliferation medium [Dulbecco's modiﬁed
EaglemediumandHams F12, (3:1) supplementedwith B27 (Invitrogen
GmBH, Karlsruhe, Germany)], 20 ng/ml epidermal growth factor (EGF;
Biosource, Karlsruhe, Germany), 20 ng/ml recombinant human ﬁbro-
blast growth factor (rhFGF; R&D Systems, Wiesbaden-Nordenstadt,
Germany), and penicillin and streptomycin (1:100 vol/vol; Invitrogen)
at 37 °C with 7.5% CO as previously described (Balbuena et al., 2012).
Differentiation was initiated by growth factor withdrawal in differenti-
ation medium [Dulbecco's modiﬁed Eagle medium and Hams F12 (3:1)
supplemented with N2 (Invitrogen)] and plating onto a poly-D-lysine/
laminin matrix.
2.2. Chemical exposure
For proliferation analysis, neurospheres were treated for 2 weeks
with Malathion (El Nasr for Chemical supplies, Egypt) (0.25, 1, or
10 μM) in proliferation medium. The doses were concluded following
preliminary study using at leastﬁve concentrations in serial two-fold di-
lutions around the EC 50-Death (half-maximal effective concentration
inducing neuronal cell death) for Malathion. This is to reach the opti-
mum dose that can affect functions of neurospheres without affecting
viability of the cells.
2.3. Proliferation analyses
For proliferation analysis, sphereswere cultured in proliferationme-
dium. After 0, 3, 7 and 14 days, sphere size was determined by software
analyses (Cell Proﬁler, version 2.1; Broad Institute, freely downloaded
from http://www.cellproﬁler.org). Diameter of each neurosphere was
measured and exported to excel ﬁle further to statistical analysis.
2.4. Differentiation analyses
For analysis of differentiation, following initiation of differentiation
as described previously, images of plated neurospheres were evaluated
regarding distinct neuronal morphology with fasciculation of neurites
that radiate from the central aggregation of neuronal perikarya.
2.5. Reduced glutathione (GSH) determination
Total GSH was determined using glutathione reductase and NADPH
coupled reaction with 5,5′-dithiobis (2-nitrobenzoic acid) as de-
scribed previously (Valentovic et al., 2004); values were expressed
as nmol/g tissue. Glutathione disulﬁde (GSSG) wasmeasured following
2-vinylpyridine derivatization and expressed as nmol/g tissue. The
results were expressed as percentage of control values.
2.6. Lipid peroxidation
Lipid peroxidationwasmeasured as described previously (Valentovic
et al., 2004). The amount of malondialdehyde (MDA) was calculated
based on a standard curve (range 1–40 nmol) using MDA (Aldrich,
St. Louis, MO) and expressed as μmol MDA/mg protein. The results
were expressed as percentage of control values.
2.7. Superoxide dismutase (SOD)
SOD activity was measured using the BIOXYTECH SOD-525 kit (Oxis
International), using the method described previously (Takahashi,
2000). The results were expressed as percentage of control values.
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Cholinesterase activity was determined following the method of
Ellman et al. (1961). The assay was carried out in the following steps:
For each sample, two tubes containing 4 ml substrate solution [20 mN
Tris buffer at pH 8.2 with 20 mM magnesium chloride (MgCl2) and
100 mM NaCl, 0.001 M Dithio-2-nitrobenzoic acid (DTNB) as reagent],
and 0.001 M acetylcholine iodide, as substrate, were pre-incubated at
37 °C in a water bath for 10 min. Into each tube, 20 μl of cell culture
was added. The sample was vortexed and transferred into a cuvette
for absorption rating. Absorption reading was taken at one-minute
time intervals for 3 min using a spectrophotometer (Shimadzu UV-
3000; Shimadzu Corporation; Kyoto, Japan) at 412 nm. A substrate
free blank was run in parallel with each sample tested.
3. Statistical analyses
The experiments were made in triplicate. All data were given as the
mean of the three samples ± standard deviation (SD). Two groups of
data were analyzed by Student's t-test. Three groups of data were ana-
lyzed by analysis of variance (ANOVA) with a Tukey post hoc test. For
all tests, p b 0.05was deemed signiﬁcantwhile p b 0.001was considered
highly signiﬁcant.
4. Results
4.1. Proliferation analysis
As shown in Table 1; control group of neurospheres showed normal
pattern of proliferation, where applying size analysis for the cell cul-
tured revealed progressive increase from 176 ± 56.3 μm in day 0 till
reaching 800.6 ± 117 μm. Malathion exposed cell cultures, revealed
arrest in proliferation which was positively correlated to the increase
in Malathion concentrations. Cells exposed to Malathion (0.25 μM)
showed arrest of neurosphere diameter in days 7 and 14, so that their
sizes were highly signiﬁcantly lower when compared to control group.
Proliferation of cells exposed to Malathion (1 μM) was signiﬁcantly
arrested as indicated by signiﬁcant decrease in size as compared to con-
trols on days 3 and 7,while on day 14 the neurospheres lost their shape.
The same pattern of proliferation arrest was noticed for Malathion at
10 μM but not 0.25 μM.
4.2. Differentiation analysis
As shown in Fig. 1; following initiation of differentiation, neurospheres
in the control group showed distinct neuronal morphology with fascic-
ulation of neuritis. However, Malathion treated neurospheres failed to
show this neurogenic differentiation.
4.3. Oxidative stress assays
As shown in Table 2; parameters measure oxidative stress revealed
no difference compared to control. MDA, GSH and SODwere all compa-
rable to the levels of control group in the Malathion exposed groups.Table 1
Proliferation analysis of different groups.
Days Control Malathion
0.25 μM
Malathion
1 μM
Malathion
10 μM
0 176 + 56.3 μm 165 + 77.4 μm 175 + 64.2 μm 155 + 56.8 μm
3 302.4 + 42.8 μm 287 + 84 μm⁎ 331.2 + 71 μm 214.2 + 27.8 μm
7 633 + 12.3 μm 413 + 21.3 μm⁎⁎ 408.1 + 24 μm⁎⁎ 309.8 + 4.8 μm⁎⁎
14 800.6 + 117 μm 411.3 + 16 μm⁎⁎ N/A N/A
⁎ Statistically signiﬁcant (p b 0.05) compared to control.
⁎⁎ Highly signiﬁcant (p b 0.001) compared to control.4.4. AchE assay
As shown in Table 3; AchE activity declined in a highly signiﬁcant
pattern compared to control in all Malathion treated groups. This de-
cline in esterase activity was dose dependent.
5. Discussion
Developmental neurotoxicity (DNT) comprises a broad category of
neurological disorders that may be of unknown etiology. Examples
include learning defects, psychological disorders (e.g. schizophrenia
and autism) and morphological damage (e.g. decrease in brain size)
(Hass, 2006). The potential contribution of environmental chemical
exposure is a major concern; hence, it is of paramount importance to
accurately predict the neurotoxic effects of these chemicals using
more advanced high throughput systems alternatives to animal studies
(Rice and Barone, 2006). In the present study, we investigated the DNT
of Malathion with different concentrations on 3D neurosphere system.
Neurospheres are thought to trace the predicted effects on different
stages of brain development. This advantage of neurospheres in-vitro
system over traditional animal models, improves our ability to verify
the putative adverse effects of Malathion on children brain develop-
ment in case of exposure in early life. The current study used low
doses (0.25 μM, 1 μM and 10 μM) of Malathion to imitate the regular
life exposure, especially through lactation. This is in contrast to most
preceding studies where much higher doses were used (1–20 mM)
(Balbuena et al., 2011, 2012; Galántai et al., 2011; Moore et al., 2010).
Although previous studies showed neurotoxic effects of Malathion on
animal models and cell cultures, results could not be extrapolated
to normal exposure due to larger doses used in these studies (Selmi
et al., 2012; Vidair, 2004; da Silva et al., 2006; Ostrea et al., 2012).
Since most of exposure studies revealed very low concentrations of
Malathion in the environment compared to acute exposure doses
(Sankararamakrishnan et al., 2005; Agarwal et al., 2015), it is more ap-
propriate to study lower dose than those used in previous researches. In
the current study, a preliminary dose response study was performed to
choose the doses that are capable of affecting different neurosphere
functions with minimal impact on cell viability. This approach is more
suitable for developmental studies, since the impact of toxic agents in
such scenario is usually due to chronic exposure to very low doses.
This is contradictory to using large doses that may lead to acute effects
and usually affects cell viability. Moors et al. (2009) have shown that:
a) proliferation, migration, differentiation, and apoptosis of human
neurospheres can be quantiﬁed; b) in vivo effects of the developmental
neurotoxicant could be imitated in vitro using Mercury as a prototype
of developmental neurotoxicant; and c) the methods applied are suit-
able for medium-throughput screening. Thus, the three-dimensional
neurosphere system offers a useful method for DNT hazard identiﬁca-
tion.However, neurophere utility as a screening system for developmen-
tal neurotoxicity is limited to basic processes of brain development
including; brain growth and proliferation, migration, differentiation
and apoptosis. This is due to the fact that they do not simulate complex
higher brain structure development. Furthermore, neurosphere system
cannot perform drug metabolism, compared to in vivo studies. This
advocates the use of complimentary strategies e.g. incubation with
S9 mixes or hepatocyte co-culture to include “maternal metabolism” in
neurosphere system (Moors et al., 2009).
The effects of Malathion were tested regarding proliferation, dif-
ferentiation capacity and viability of neurospheres. Furthermore, the
mechanisms of such neurotoxic effects (e.g. AchE inhibiting and pro-
oxidant effects) of Malathion were veriﬁed in cell culture. The effects
of Malathion on proliferation were evident as noticed through the
arrest of normal increase in neurosphere diameter with progress of
time in a proliferation culture medium. Meanwhile, differentiation
of neurospheres to neuritis was inhibited by addition of Malathion to
the differentiation medium. Also, Malathion decreased the viability of
Fig. 1. Image of plated neurospheres after 1 week. Panel A (control × 40) shows distinct neuronal morphology with fasciculation of neurites that radiate from the central aggregation of
neuronal perikarya. In contrast, panel B (Malathion 1 and 10 μM × 20) shows the absence of such neurological differentiation with neurospheres of the same appearance as in day 0.
Scale bar: 100 μm.
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effects suggest strong developmental neurotoxic effects of Malathion
during the critical period of brain development (Moors et al., 2009;
Schreiber et al., 2010). The multiple effects induced by Malathion on
neurosphere system underscore the more global effects of Malathion
compared to other tested neurotoxic agents evaluated in other studies
(Moors et al., 2009; Schreiber et al., 2010), hence, its more powerful
sequelae for children exposure. Two potential mechanisms have been
suggested for these DNT effects of Malathion viz.; oxidative stress
(Fortunato et al., 2006; Delgado et al., 2006) and inhibition of AchE
enzyme (Selmi et al., 2012). The present study shows that assays of
oxidative stress had no difference in comparison to control. This ﬁnding
can be attributed to the fact that the current study used smaller doses
compared to previous similar works by Delgado et al. (2006) and
Moore et al. (2010) which used higher concentrations of Malathion
(1–24 mM). The use of these smaller doses may be helpful to elucidate
the toxic effects andmechanisms in real life exposure. Moreover, previ-
ous studies comparing between human neural progenitor cells (hNPCs)
and the human neuroblastoma cell line SH-SY5Y showed that hNPCsTable 2
Oxidative stress assays.
MDA Reduced GSH SOD
0.25 μMMalathion — 1 week 99 + 4% 92 + 3% 110 + 7%
0.25 μMMalathion — 2 weeks 130 + 3.1% 110 + 4.2% 90 + 2.7%
1 μMMalathion — 1 week 98 + 7.4% 90 + 4.8% 90 + 7.1%
1 μMMalathion — 2 weeks 140 + 9.2% 120 + 8.1% 110 + 7.7%
10 μMMalathion — 1 week 100 + 6.3% 85 + 3.9% 100 + 3.4%
10 μMMalathion — 2 weeks 120 + 8.6% 100 + 3.8% 100 + 4.2%
# All measurements are percentage compared to control group of similar period.were less sensitive towards oxidative stress (Moors et al., 2009),
which is in concert with the knowledge that primary cells are less
sensitive to various stressors than cancer cells (Hileman et al., 2004;
DiMasi, 2001). This was conﬁrmed shortly after by the work of
Schreiber et al. (2010) who attributed the better defense mechanisms
of neurospheres than do postmitotic neural cells to the high GSH con-
tent of associated astrocytes (Madhavan et al., 2006). These previous
studies suggest that oxidative stress' rolemay beminor inMalathion in-
duced DNT due to the less vulnerability of growing brains than in adults
when used with regular doses. In contrast, AchE level was signiﬁcantly
decreased in Malathion treated groups. This ﬁnding supports the role
of esterase lowering effects of Malathion as a potential mechanism
of its developmental neurotoxic effects. The lower levels of AchE in
growing brains would make them more vulnerable to any further de-
cline in activity as in the case of Malathion exposure (Selmi et al.,
2012; Acker et al., 2011; Vidair, 2004; da Silva et al., 2006). So, based
on our ﬁndings, low dose exposure to Malathion causes its neurotoxic
effects on growing brain neurons through inhibiting the protective
AchE activity. AChE is a critical player in the regulation of severalTable 3
% of AchE in the three treated groups compared to control.
AchE assay
Control 100%
0.25 μMMalathion 34 + 2.1%⁎⁎
1 μMMalathion 28 + 3.4%⁎⁎
10 μMMalathion 17 + 4.8%⁎⁎
# Statistically signiﬁcant (p b 0.05) compared to control.
⁎⁎ Highly signiﬁcant (p b 0.001) compared to control.
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linergic system is important in maintaining normal behavior and mus-
cular function (Payne et al., 1996). In several neurological disorders,
activity of AChE has been altered, for instance, Acker et al. (2011),
showed that exposure to different doses of Malathion inhibited AChE
activity in brains of rats' pups. In their study high dose of Malathion
(200 mg/kg) caused more AChE inhibition and more behavioral alter-
ations than at the dose of 100 mg/kg, suggesting a link between AChE
inhibition and behavioral impairment. Since cholinergic system has im-
portant functions in brain development, OP pesticides exposure during
the developmental period can interfere with neurotransmitter function
leading to neurodevelopmental abnormalities (Slotkin, 2004). Animals
exposed to AChE inhibitors during the postnatal period of active synap-
togenesis are vulnerable to develop several behavioral impairments,
including motor development/coordination deﬁcits (Dam et al., 2000).
This is because, during brain development, acetylcholine and choliner-
gic projections playmajor roles in proliferation,migration, and synapto-
genesis and in the development of normal neural cytoarchitecture
(Hohmann, 2003).
6. Conclusions and clinical application
In humans, the developing nervous system is highly vulnerable to
the deleterious effects of environmental toxins e.g. etiology of schizo-
phrenia and autism are assumed to result from the deleterious effects
of environmental factors during normal brain growth spurt (Rice and
Barone, 2006). Consequently, to prevent harm, there is an increasing
need for developmental neurotoxicity (DNT) to test chemical com-
pounds in general use and determines which one is considered a devel-
opmental neurotoxin (Coecke et al., 2007; Goldman andKorduru, 2000;
Hass, 2006; Needleman et al., 2002). There is an increasing concern
about exposure of pregnant women, infants and children to OPs.
Children in agricultural communities, like Egypt, carry the risk of
continuous exposure to acetylcholinesterase inhibitors through hand
to mouth behavior (Eskenazi et al., 1999). Children are considered
to be more vulnerable due to the signiﬁcant anatomical and matura-
tional changes occurring in the brain during developmental periods
(Andersen, 2003). Moreover, Acker et al. (2011) showed that re-
peated exposure to small doses of Malathion is capable of producing
behavioral impairment in rat pups. This was proved by signiﬁcant
decrease in motor coordination, vestibular function and muscular
strength/coordination, negative geotaxis and forelimb support tests,
respectively. More interestingly, the degree of behavioral impair-
ments was signiﬁcantly correlated to the activity of AChE in brains
of rat pups that was demonstrated.
The ﬁndings of the present study conﬁrm the negative impact of
Malathion on proliferation, differentiation and viability of NPCs, which
reﬂects possible developmental disorders that can affect different end-
points for the growing brains. This is in accordance with Selmi et al.
(2012), Vidair (2004), and da Silva et al. (2006). These studies, however,
showed the neurotoxic effects of early postnatal exposure in rodent
models. Although they reﬂected the abnormal neurobehavioral perfor-
mance of children exposed to pesticides like Malathion in early life
(Ostrea et al., 2012), they needed to be veriﬁed by more detailed
study as in neurosphere system. To the best of our knowledge, we are
the ﬁrst team to conﬁrm the DNT of Malathion on 3D neurosphere
model. In addition the present work conﬁrmed the critical role played
by the AchE decreased activity in developing such effects. On the
other hand there is no observed role for oxidative stress in Malathion
induced DNT in a neurosphere system.
Acknowledgments
This work was supported by a grant from the Medical Experimental
Research Center of Mansoura University (MERC) (14-002).References
Abdel-Rahman, A., Dechkovskaia, A.M., Goldstein, L.B., Bullman, S.H., Khan, W., ElMasry,
E.M., Abou-Donia, M.B., 2004. Neurological deﬁcits induced by malathion, DEET,
and permethrin, alone or in combination in adult rats. J. Toxic. Environ. Health A
67, 331–356.
Abou-Donia, M.B., 2003. Organophosphorus ester-induced chronic neurotoxicity. Arch.
Environ. Health 58 (8), 484–497.
Acker, C.I., Souza, A.C., Pinton, S., da Rocha, J.T., Friggi, C.A., Zanella, R., Nogueira, C.W.,
2011. Repeated malathion exposure induces behavioral impairment and AChE
activity inhibition in brains of rat pups. Ecotoxicol. Environ. Saf. 74 (8), 2310–2315.
Agarwal, A., Prajapati, R., Singh, O.P., Raza, S.K., Thakur, L.K., 2015. Pesticide residue in
water, a challenging risk in India. Environ. Monit. Assess. 187 (2), 54.
Andersen, S.L., 2003. Trajectories of brain development: point of vulnerability or window
of opportunity. Neurosci. Biobehav. Rev. 27, 3–18.
Balbuena, P., Li, W., Ehrich, M., 2011. Assessments of tight junction proteins occludin,
claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood–
brain barrier: cellular responses to neurotoxicants malathion and lead acetate.
Neurotoxicology 32 (1), 58–67.
Balbuena, P., Li, W., Rzigalinski, B.A., Ehrich, M., 2012. Malathion/oxon and lead acetate in-
crease gene expression and protein levels of transient receptor potential canonical
channel subunits TRPC1 and TRPC4 in rat endothelial cells of the blood–brain barrier.
Int. J. Toxicol. 31 (3), 238–249.
Coecke, S., Goldberg, A.M., Allen, S., Buzanska, L., Calamandrei, G., Crofton, K., Hareng, L.,
Hartung, T., Knaut, H., Honegger, P., Jacobs, M., Lein, P., Li, A., Mundy, W., Owen, D.,
Schneider, S., Silbergeld, E., Reum, T., Trnovec, T., Monnet-Tschudi, F., Bal-Price, A.,
2007.Workgroup report: incorporating in vitro alternative methods for developmen-
tal neurotoxicity into international hazard and risk assessment strategies. Environ.
Health Perspect. 115, 924–931.
Collins, F.S., Gray, G.M., Bucher, J.R., 2008. Toxicology. Transforming environmental health
protection. Science 319, 906–907.
da Silva, A.P., Meotti, F.C., Santos, A.R., Farina, M., 2006. Lactational exposure to malathion
inhibits brain acetylcholinesterase in mice. Neurotoxicology 27 (6), 1101–1105.
Dallegrave, E., Mantese, F.D., Oliveira, R.T., Andrade, A.J.M., Dalsenter, P.R., Langeloh, A.,
2007. Pre- and postnatal toxicity of the commercial glyphosate formulation inWistar
rats. Arch. Toxicol. 81, 665–673.
Dam, K., Seidler, F.J., Slotkin, T.A., 2000. Chlorpyrifos exposure during a critical neonatal
period elicits gender-selective deﬁcits in the development of coordination skills and
locomotor activity. Dev. Brain Res. 121, 179–187.
Delgado, E.H., Streck, E.L., Quevedo, J.L., Dal-Pizzol, F., 2006. Mitochondrial respiratory
dysfunction and oxidative stress after chronic malathion exposure. Neurochem. Res.
31 (8), 1021–1025.
DiMasi, J.A., 2001. Risks in new drug development: approval success rates for investiga-
tional drugs. Clin. Pharmacol. Ther. 69, 297–307.
Ellman, G.L., Courtney, K.D., Andres Jr., V., Feather-Stone, R.M., 1961. A new and rapid
colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7,
88–95.
Environ. Prot. Agency (USA), 2002. Pesticide Industry Sales and Usage: 1998 and 1999
Market Estimates. USEPA, Washington, DC.
Eskenazi, B., Bradman, A., Castorina, R., 1999. Exposures of children to organophosphate
pesticides and their potential adverse health effects. Environ. Health Perspect. 107,
409–419.
Fortunato, J.J., Agostinho, F.R., Réus, G.Z., Petronilho, F.C., Dal-Pizzol, F., Quevedo, J., 2006.
Lipid peroxidative damage onmalathion exposure in rats. Neurotox. Res. 9 (1), 23–28.
Galántai, R., Emody-Kiss, B., Somosy, Z., Bognár, G., Horváth, G., Forgács, Z., Gachályi, A.,
Szilasi, M., 2011. Does malaoxon play a role in the geno- and cytotoxic effects of mal-
athion on human choriocarcinoma cells? J. Environ. Sci. Health B. 46 (8), 773–779.
Genschow, E., 2002. Phase and evaluation of prediction models. European Centre for the
Validation of Alternative Methods. Altern. Lab. Anim. 30, 151–176.
Goldman, L.R., Korduru, S., 2000. Chemicals in the environment and developmental
toxicity to children: a public health and policy perspective. Environ. Health Perspect.
108, 442–448.
Hass, U., 2006. The need for developmental neurotoxicity studies in risk assessment for
developmental toxicity. Reprod. Toxicol. 22, 148–156.
Hazarika, A., Sarkar, S.N., Hajare, S., Kataria, M., Malik, J.K., 2003. Inﬂuence of malathion
pretreatment on the toxicity of anilofos in male rats: a biochemical interaction
study. Toxicology 185, 1–8.
Hileman, E.O., Liu, J., Albitar, M., Keating, M.J., Huang, P., 2004. Intrinsic oxidative stress in
cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother.
Pharmacol. 53, 209–219.
Hohmann, C.F., 2003. A morphogenetic role for acetylcholine in mouse cerebral neocor-
tex. Neurosci. Biobehav. Rev. 27, 351–363.
Iwanami, A., Kaneko, S., Nakamura, M., Kanemura, Y., Mori, H., Kobayashi, S., Yamasaki,
M., Momoshima, S., Ishii, H., Ando, K., Tanioka, Y., Tamaoki, N., Nomura, T., Toyama,
Y., Okano, H., 2005. Transplantation of human neural stem cells for spinal cord injury
in primates. J. Neurosci. Res. 80, 182–190.
Kiely, T.G.A., 2004. Pesticides Industry Sales and Usage: 2000 and 2001 Market Estimates.
US EPA, Washington DC.
Lein, P., Locke, P., Goldberg, A., 2007. Meeting report: alternatives for developmental neu-
rotoxicity testing. Environ. Health Perspect. 115, 764–768.
Lein, P., Silbergeld, E., Locke, P., Goldberg, A., 2005. In vitro and other alternative ap-
proaches to developmental neurotoxicity testing (DNT). Environ. Toxicol. Pharmacol.
19, 735–744.
Madhavan, L., Ourednik, V., Ourednik, J., 2006. Increased “vigilance” of antioxidant mech-
anisms in neural stem cells potentiates their capabilities to resist oxidative stress.
Stem Cells 24, 2110–2119.
18 M. Salama et al. / Applied & Translational Genomics 7 (2015) 13–18Maroni, M., Colosio, C., Ferioli, A., Fait, A., 2000. Biological monitoring of pesticide expo-
sure: a review, introduction. Toxicology 7, 1–118.
Meacham, C.A., Freudenrich, T.M., Anderson, W.L., Sui, L., Lyons-Darden, T., Barone Jr., S.,
Gilbert, M.E., Mundy, W.R., Shafer, T.J., 2005. Accumulation of methylmercury or
polychlorinated biphenyls in in vitro models of rat neuronal tissue. Toxicol. Appl.
Pharmacol. 205, 177–187.
Moore, P.D., Yedjou, C.G., Tchounwou, P.B., 2010. Malathion-induced oxidative stress, cy-
totoxicity, and genotoxicity in human liver carcinoma (HepG2) cells. Environ. Toxicol.
25 (3), 221–226.
Moors, M., Rockel, T.D., Abel, J., Cline, J.E., Gassmann, K., Schreiber, T., Schuwald, J.,
Weinmann, N., Fritsche, E., 2009. Human neurospheres as three-dimensional cellular
systems for developmental neurotoxicity testing. Environ. Health Perspect. 117 (7),
1131–1138.
Needleman, H.L., McFarland, C., Ness, R.B., Fienberg, S.E., Tobin, M.J., 2002. Bone lead levels
in adjudicated delinquents. A case control study. Neurotoxicol. Teratol. 24, 711–717.
Organisation for Economic Co-operation and Development, 2007. Guideline for the
Testing of Chemicals. Section 4: Health Effects Test No. 426: Developmental Neuro-
toxicity Study. Organisation for Economic Co-operation and Development, Paris.
Ostrea Jr., E.M., Reyes, A., Villanueva-Uy, E., Paciﬁco, R., Benitez, B., Ramos, E., Bernardo,
R.C., Bielawski, D.M., Delaney-Black, V., Chiodo, L., Janisse, J.J., Ager, J.W., 2012. Fetal
exposure to propoxur and abnormal child neurodevelopment at 2 years of age.
Neurotoxicology 33 (4), 669–675.
Patil, V.K., David, M., 2010. Behavioral and morphological endpoints: as an early response
to sublethal malathion intoxication in the freshwater ﬁsh, Labeo rohita. Drug Chem.
Toxicol. 33 (2), 160–165.
Payne, J.F., Mathiew, A., Melving, W., Fancey, L.L., 1996. Acetylcholinesterase, an old bio-
marker with a new future? Field trials in association with two urban rivers and a
paper mill in Newfoundland. Mar. Pollut. Bull. 32, 225–231.
Registration Eligibility Decision (RED)—Malathion, 2006. ; EPA 738-R-06–030; U.S. Envi-
ronmental Protection Agency, Ofﬁce of Prevention, Pesticides and Toxic Substances,
Ofﬁce of Pesticide Programs. U.S. Government Printing Ofﬁce, Washington, DC.
Rice, D., Barone, S., 2006. Critical periods of vulnerability for the developing nervous
system: evidence from humans and animal models. Environ. Health Perspect. 108
(Suppl. 3), 511–533.
Rohlman, D.S., Anger,W.K., Lein, P.J., 2011. Correlating neurobehavioral performancewith
biomarkers of organophosphorous pesticide exposure. Neurotoxicology 32 (2),
268–276.Russel, W.M.S., Burch, R.L., 1959. The Principles of Humane Experimentation Technique.
Universities Federation for Animal Welfar, Wheathampstead, UK (reprinted 1992).
Sankararamakrishnan, N., Kumar Sharma, A., Sanghi, R., 2005. Organochlorine and organ-
ophosphorus pesticides residues in ground water and surface waters of Kanpur,
Uttar, Pradesh, India. Environ. Int. 31 (1), 113–120.
Schetinger, M.R.C., Porto, N.M., Moretto, M.B., Morsch, V.M., Rocha, J.B.T., Vieira, V., Moro,
F., Neis, R.T., Bittencourt, S., Bonacorso, H.G., Zanatta, N., 2000. New benzodiazepines
alter acetylcholinesterase and ATPase activities. Neurochem. Res. 25, 949–955.
Schreiber, T., Gassmann, K., Götz, C., Hübenthal, U., Moors, M., Krause, G., Merk, H.F.,
Nguyen, N.H., Scanlan, T.S., Abel, J., Rose, C.R., Fritsche, E., 2010. Polybrominated
diphenyl ethers induce developmental neurotoxicity in a human in vitro model:
evidence for endocrine disruption. Environ. Health Perspect. 118 (4), 572–578.
Selmi, S., El-Fazaa, S., Gharbi, N., 2012. Oxidative stress and cholinesterase inhibition
in plasma, erythrocyte and brain of rats' pups following lactational exposure to
malathion. Environ. Toxicol. Pharmacol. 34 (3), 753–760.
Slotkin, T.A., 2004. Cholinergic systems in brain development and disruption by
neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol.
Appl. Pharmacol. 198, 132–151.
Takahashi, K., 2000. Glutathione peroxidase: coupled enzyme assay. In: Taniguchi, N.,
Gutteridge, J.M.C. (Eds.), Experimental Protocols for Reactive Oxygen and Nitrogen
Species. Oxford University Press, Oxford, United Kingdom, pp. 79–80.
Valentovic, M., Terneus, M., Harmon, R.C., Carpenter, A.B., 2004. S-adenosylmethionine
(SAMe) attenuates acetaminophen hepatotoxicity in C57BL/6 mice. Toxicol. Lett.
154 (3), 165–174.
Vidair, C.A., 2004. Age dependence of organophosphate and carbamate neurotoxicity in
the postnatal rat: extrapolation to the human. Toxicol. Appl. Pharmacol. 196 (2),
287–302.
Wang, L.M., Ye, W.H., Zhou, S.S., Lin, K.D., Zhao, M.R., Liu, W.P., 2009. Acute and chronic
toxicity of organophosphate monocrotophos to Daphnia magna. J. Environ. Sci Health
B 44, 38–43.
Yanai, J., 1984. Neurobehavioral Teratology. Elsevier, Amsterdam.
Yen, J.H., Lin, K.H., Wang, Y.S., 2000. Potential of the insecticides acephate and
methamidophos to contaminate groundwater. Ecotoxicol. Environ. Saf. 45, 79–86.
Zhang, S.C.,Wernig,M., Duncan, I., Brustle, O., Thomson, J.A., 2001. In vitro differentiation of
transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol.
19, 1129–1133.
